Literature DB >> 12915504

Case-crossover and case-time-control designs in birth defects epidemiology.

Sonia Hernández-Díaz1, Miguel A Hernán, Katie Meyer, Martha M Werler, Allen A Mitchell.   

Abstract

The case-crossover and the case-time-control designs can be used to evaluate the effect of intermittent exposures on the risk of acute events. To explore how birth defects epidemiology could benefit from these approaches, the authors compared them with a traditional case-control study design that evaluated the association between use of folic acid antagonists during the second and third pregnancy months and the risk of cardiovascular defects. Among 3,870 cases and 8,387 control infants in the Slone Epidemiology Center Birth Defects Study (1976-1998), the odds ratio was 2.3 (95% confidence interval (CI): 1.4, 3.9). The case-crossover approach compared folic acid antagonist use between the 2-month embryologically sensitive period (case window) and the 2 months preceding the last menstrual period (control window) among mothers of case infants (odds ratio = 1.0, 95% CI: 0.5, 2.0). Although it controls between-person confounding and avoids issues of control selection, this design may be biased by time trends of exposure prevalence during pregnancy. The case-time-control design, which adjusts for exposure time trends under certain assumptions, yielded an odds ratio of 2.9 (95% CI: 1.2, 7.2), but it requires controls. In the presence of gestational time trends of exposure, the new designs do not offer clear advantages over the case-control design.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915504     DOI: 10.1093/aje/kwg144

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

Review 1.  Appending epidemiological studies to conventional case-control studies (hybride case-control studies).

Authors:  Andreas Stang; Karl-Heinz Jöckel
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Epidemiologic methods: beyond clinical medicine, beyond epidemiology.

Authors:  Francisco Bolúmar; Miquel Porta
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

3.  Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in Senegal.

Authors:  Stephanie Dellicour; Philippe Brasseur; Per Thorn; Oumar Gaye; Piero Olliaro; Malik Badiane; Andy Stergachis; Feiko O ter Kuile
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

4.  Future cases as present controls to adjust for exposure trend bias in case-only studies.

Authors:  Shirley Wang; Crystal Linkletter; Malcolm Maclure; David Dore; Vincent Mor; Stephen Buka; Gregory A Wellenius
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

Review 5.  Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.

Authors:  Md Jamal Uddin; Rolf H H Groenwold; Mohammed Sanni Ali; Anthonius de Boer; Kit C B Roes; Muhammad A B Chowdhury; Olaf H Klungel
Journal:  Int J Clin Pharm       Date:  2016-04-18

Review 6.  Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy.

Authors:  Krista F Huybrechts; Brian T Bateman; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-05-10       Impact factor: 2.890

7.  Antibiotics and oral contraceptive failure - a case-crossover study.

Authors:  Sengwee Toh; Allen A Mitchell; Marlene Anderka; Lolkje T W de Jong-van den Berg; Sonia Hernández-Díaz
Journal:  Contraception       Date:  2010-10-08       Impact factor: 3.375

8.  Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.

Authors:  Antonella Zambon; Hernan Polo Friz; Paolo Contiero; Giovanni Corrao
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Risk of injury due to alcohol: evaluating potential bias using the case-crossover usual-frequency method.

Authors:  Yu Ye; Jason Bond; Cheryl J Cherpitel; Tim Stockwell; Scott Macdonald; Jürgen Rehm
Journal:  Epidemiology       Date:  2013-03       Impact factor: 4.822

10.  Effects of anticholinergic and sedative medication use on fractures: A self-controlled design study.

Authors:  Shahar Shmuel; Virginia Pate; Marc J Pepin; Janine C Bailey; Yvonne M Golightly; Laura C Hanson; Til Stürmer; Rebecca B Naumann; Danijela Gnjidic; Jennifer L Lund
Journal:  J Am Geriatr Soc       Date:  2021-07-22       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.